Bay City Capital Llc's Net Worth
Bay City Capital Llc's net worth is estimated to be at least $253,394,692.50 as of 12/23/2024. CoreStreet's estimation of Bay City Capital Llc's net worth is based on their sale of stock and current holding of stock.
Bay City Capital Llc is Major Shareholder at Madrigal Pharmaceuticals Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 7,303 units of MDGL stock on 08/19/2020. Their biggest sale was on 12/13/2019 when they sold 1,200,000 units of Madrigal Pharmaceuticals Inc stock for $126,564,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $1,105,792.00
Total value of insider sells:
- $252,288,900.50
Most recent insider trade:
- Aug. 19, 2020
Bay City Capital Llc's Insider Trading History
| Madrigal Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 19, 2020 | Major Shareholder | 7,303 | $107.64 | Sell | $786,094.92 |
Aug. 17, 2020 | Major Shareholder | 12,500 | $110.73 | Sell | $1,384,125.00 |
Dec. 13, 2019 | Major Shareholder | 1,200,000 | $105.47 | Sell | $126,564,000.00 |
June 11, 2018 | Director | 280,000 | $287.46 | Sell | $80,488,800.00 |
| Nevro Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 8, 2015 | Insider | 491,835 | $47.94 | Sell | $23,578,569.90 |
| Journey Medical Corporation Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 8, 2014 | Director | 69,112 | $16.00 | Buy | $1,105,792.00 |
| Epizyme Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 26, 2014 | Major Shareholder | 200,000 | $35.14 | Sell | $7,028,000.00 |
Aug. 25, 2014 | Major Shareholder | 366,666 | $33.98 | Sell | $12,459,310.68 |